IMB-T130

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameIMB-T130
Drug Alias NameIMB-T-130IMB-T130
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsTuberculosis, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsTuberculosis, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A